NICE Is Back In Business, And So Are Its Critics
This article was originally published in The Pink Sheet Daily
Executive Summary
UK Prime Minister David Cameron is petitioned to reverse NICE's rejection of Celgene's Vidaza, on the same day that NICE resumes issuing guidelines.